Back
Also listed as
GGNDF
OTC
Day Range
$44.51
$45.11
52-Week Range
$36.83
$57.22
Volume
400
50D / 200D Avg
$47.63
/
$49.03
Prev Close
$43.90
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 3.3 | 0.4 |
| P/B | 0.2 | 2.9 |
| ROE % | 6.0 | 3.8 |
| Net Margin % | 3.9 | 3.9 |
| Rev Growth 5Y % | 1.6 | 10.0 |
| D/E | 1.0 | 0.2 |
Key Takeaways
Revenue grew 1.56% annually over 5 years — modest growth
Earnings declined -33.91% over the past year
Generating 1.14B in free cash flow
P/E of 3.32 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.25%
Cash machine — converts 174.12% of earnings into free cash flow
Growth
Revenue Growth (5Y)
1.56%
Revenue (1Y)-6.69%
Earnings (1Y)-33.91%
FCF Growth (3Y)-2.90%
Quality
Return on Equity
6.01%
ROIC5.51%
Net Margin3.89%
Op. Margin9.51%
Safety
Debt / Equity
0.99
Current Ratio1.18
Interest Coverage2.57
Valuation
P/E Ratio
3.32
P/B Ratio0.20
EV/EBITDA7.43
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -6.69% | Revenue Growth (3Y) | -3.76% |
| Earnings Growth (1Y) | -33.91% | Earnings Growth (3Y) | 69.23% |
| Revenue Growth (5Y) | 1.56% | Earnings Growth (5Y) | -21.91% |
| Profitability | |||
| Revenue (TTM) | 16.78B | Net Income (TTM) | 653.00M |
| ROE | 6.01% | ROA | 2.23% |
| Gross Margin | 54.56% | Operating Margin | 9.51% |
| Net Margin | 3.89% | Free Cash Flow (TTM) | 1.14B |
| ROIC | 5.51% | FCF Growth (3Y) | -2.90% |
| Safety | |||
| Debt / Equity | 0.99 | Current Ratio | 1.18 |
| Interest Coverage | 2.57 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 3.32 | P/B Ratio | 0.20 |
| P/S Ratio | 0.13 | PEG Ratio | -0.65 |
| EV/EBITDA | 7.43 | Dividend Yield | 0.01% |
| Market Cap | 2.17B | Enterprise Value | 11.86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 16.78B | 17.99B | 18.12B | 18.69B | 15.78B |
| Net Income | 653.00M | 988.00M | 228.00M | 511.00M | 1.76B |
| EPS (Diluted) | 12.93 | 20.34 | 4.92 | 11.97 | 40.47 |
| Gross Profit | 9.16B | 9.56B | 9.04B | 9.13B | 8.68B |
| Operating Income | 1.60B | 1.86B | 869.00M | 1.11B | 2.40B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 29.23B | 30.61B | 30.64B | 30.59B | 23.55B |
| Total Liabilities | 18.33B | 19.79B | 21.06B | 23.79B | 17.32B |
| Shareholders' Equity | 10.90B | 10.82B | 9.59B | 6.80B | 6.23B |
| Total Debt | 10.82B | 11.49B | 13.50B | 16.25B | 11.57B |
| Cash & Equivalents | 1.12B | 980.00M | 2.16B | 990.00M | 6.21B |
| Current Assets | 8.64B | 9.33B | 10.18B | 9.37B | 11.99B |
| Current Liabilities | 7.32B | 8.15B | 15.64B | 11.73B | 6.14B |